IMMvention retained rights to use its technology to potentially pursue other targets, such as Parkinson’s or Alzheimer’s ...

Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the ...

Rigel Pharmaceuticals has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, ...

WINSTON-SALEM, N.C. — Emory Moore, a 12-year-old treated at Brenner Children’s Hospital for sickle cell disease, received a special day with the Wake Forest basketball team. Despite her diagnosis, ...

The Boring Company’s Hyperloop is set to revolutionize transportation in Texas! Promising ultra-fast travel and cutting-edge technology, this futuristic system is closer than ever to becoming a ...

The Neuse-Pamlico Sound Women's Coalition is preparing for its 9th annual "March for Sickle Cell" 5K walk-run, an event aimed at raising awareness and funds to ...

Statistics from the district health department indicate that in 2023, suspected cases of sickle cells stood at 1,456 and in 2024, the registered cases were 914. Thank you for reading Nation.Africa ...

Beam Therapeutics (BEAM) announced the company will encore data from the BEACON Phase 1/2 clinical trial of BEAM-101 in sickle cell disease in ...

A plaque at the centre recognises Dame Elizabeth’s lifelong commitment to improving the care of people living with sickle cell disease and thalassaemia and heralds a new phase in NHS Blood and ...

USA-based biotech IMMvention Therapeutix yesterday revealed it has entered into a strategic collaboration and license ...

Ten new categories of persons with disabilities (PwDs) in Haryana will now be eligible for pension benefits with the council of ministers on Thursday approving amendments to the Haryana Disabled ...